{
  "market_name": "Antacids Market",
  "unit": "Billion",
  "cagr": 4.4,
  "value_2024": 7.73,
  "value_2033": 11.39,
  "REGIONAL_RANKING": {
    "first": "North America",
    "second": "Europe",
    "third": "Asia Pacific"
  },
  "EUROPE_COUNTRY_CLASSIFICATION": {
    "Germany": "dominant",
    "United Kingdom": "fastest_growing",
    "France": "emerging"
  },
  "SEGMENTS": {
    "Product Type": [
      "Formulation Type",
      "Active Ingredient Type"
    ],
    "Indication": [
      "Heartburn",
      "Gastroesophageal Reflux Disease",
      "Peptic Ulcer",
      "Functional Dyspepsia",
      "Other Acid Disorders"
    ],
    "Distribution Channel": [
      "Hospital Pharmacies",
      "Retail Pharmacies",
      "E-Commerce",
      "Other Channels"
    ],
    "End User": [
      "Adults",
      "Geriatric Population",
      "Pediatric Use"
    ],
    "Mechanism of Action": [
      "Systemic Antacids",
      "Non-Systemic Antacids"
    ]
  }
}